Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2025 Earnings Call Transcript May 12, 2025
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.79, expectations were $-1.02.
Dan Ferry – LifeSci Advisors, IR:
Jon Congleton – CEO:
Dave Rodman – Chief Medical Officer:
Adam Levy – CFO:
Michael DiFiore – Evercore ISI:
Richard Law – Goldman Sachs:
Seamus Fernandez – Guggenheim:
Rami Katkhuda – LifeSci Capital:
Operator: Good afternoon, ladies and gentlemen, and welcome to...
